Neurogene (NGNE) Change in Receivables (2013 - 2015)
Neurogene (NGNE) posted Change in Receivables of $12000.0 for Q4 2015, up 122.64% on a QoQ basis from -$53000.0 in Q3 2015, and up 209.09% year-over-year from $3882.4 in Q4 2014.
Neurogene (NGNE) Change in Receivables (2013 - 2015) Analysis & Trends
Neurogene's Change in Receivables history runs 3 years deep, the most recent figure standing at $12000.0 for Q4 2015.
- Quarterly Change in Receivables rose 209.09% year-over-year to $12000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was -$34000.0 (down 189.83% YoY) and the FY2015 annual result came in at -$34000.0, down 191.89% from the prior year.
- Change in Receivables was $12000.0 for Q4 2015 at Neurogene, up from -$53000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $43000.0 in Q3 2014 and bottomed at -$53000.0 in Q3 2015.
- A 3-year average of $270.83 and a median of -$2988.0 in 2013 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 22841.18% in 2014, while the deepest fall reached 358.06% in 2014.
- Neurogene's Change in Receivables stood at -$6146.0 in 2013, then slumped by 78.98% to -$11000.0 in 2014, then jumped by 209.09% to $12000.0 in 2015.
- Business Quant data shows NGNE's Change in Receivables at $12000.0 in Q4 2015, -$53000.0 in Q3 2015, and $15000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 12,000.00 |
| Dec 31, 2015 | 12,000.00 |
| Sep 30, 2015 | -53,000.00 |
| Sep 30, 2015 | -53,000.00 |
| Jun 30, 2015 | 15,000.00 |
| Jun 30, 2015 | 15,000.00 |
| Mar 31, 2015 | -8,000.00 |
| Mar 31, 2015 | -8,000.00 |
| Dec 31, 2014 | -11,000.00 |
| Dec 31, 2014 | -11,000.00 |
| Sep 30, 2014 | 43,000.00 |
| Sep 30, 2014 | 43,000.00 |
| Jun 30, 2014 | -33,151.00 |
| Jun 30, 2014 | -33,151.00 |
| Mar 31, 2014 | 39,000.00 |
| Mar 31, 2014 | 39,000.00 |
| Dec 31, 2013 | -6,146.00 |
| Dec 31, 2013 | -6,146.00 |
| Sep 30, 2013 | -7,469.00 |
| Sep 30, 2013 | -7,469.00 |